Brady Middle School eighth-graders took to the gym floor earlier this school year to demonstrate the skills the students ...

Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tissue platform for ...

Kooltech announces the launch of the KS1-BR41N, a new addition to their K-con bespoke solutions range. Also known as K-BRAIN, ...

A US appeals court blocked the Trump administration’s drug rebate plan, ruling safety-net hospitals cannot be forced to pay ...

The Trump administration cannot require hospitals serving low-income Americans to pay full price upfront for the first ...

A federal appeals court has blocked a Trump administration initiative that would have required hospitals serving low-income Americans to pay full prices upfront for certain high-cost prescription ...

A federal appeals court on Wednesday blocked a Trump administration plan to require hospitals serving low-income Americans to ...

Cash management is critical for pharmaceutical companies: The ability to fund drug innovation can make the difference between ...

Poplar Therapeutics Inc. launched on Wednesday capitalized with $50 million Series A financing and led by Chip Baird, the ...

HHS’s move Monday to overhaul the childhood vaccine schedule without public input marks Health Secretary Robert F. Kennedy Jr ...

Dark Blue Therapeutics ("Dark Blue"), a discovery and development biotech company pioneering the next generation of precision oncology medicines, has been acquired by Amgen (NASDAQ: AMGN).

This effort, undertaken by Bristol Myers Squibb and agency partner Real Chemistry, is part of the Champions in Care campaign.